This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Single Cell Multiomics industry.
How has the single cell multiomics market size changed in recent years, and what is the outlook ahead?
The single cell multiomics market size has grown exponentially in recent years. It will grow from $3.97 billion in 2024 to $4.85 billion in 2025 at a compound annual growth rate (CAGR) of 22.1%. The growth in the historic period can be attributed to an increase in research funding, rise in demand for personalized medicine, a growth in cancer research, an increase in the prevalence of chronic diseases, and a growth in academic and clinical research.
The single cell multiomics market size is expected to see exponential growth in the next few years. It will grow to $10.69 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to growing adoption of precision medicine, increasing focus on rare diseases, growing interest in stem cell research, increasing clinical research studies, and rising demand for high throughput screening. Major trends in the forecast period include the development of multiparameter profiling tools, advancements in spatial transcriptomics, adoption of high resolution imaging techniques, adoption of integrated omics databases, and the development of advanced bioinformatics solutions.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp
#What are the top economic and technological drivers pushing single cell multiomics market growth?
The increasing demand for precision medicine is expected to propel the growth of the single cell multiomics market going forward. Precision medicine refers to a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient. The rise in precision medicine is fueled by advancements in genomic research, enhanced data analysis capabilities, and a heightened understanding of personalized healthcare advantages. Single-cell multiomics provides detailed insights into cellular heterogeneity and molecular mechanisms, enabling the development of highly personalized treatments tailored to individual patients’ unique cellular profiles. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing demand for precision medicine is driving the growth of the single cell multiomics market.
How is the single cell multiomics market segmented by product, application, and end-user?
The single cell multiomics market covered in this report is segmented –
1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics
2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis
3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research
4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies
Subsegments:
1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms
2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms
3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools
4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report
What evolving trends are creating new opportunities in the single cell multiomics market?
Major companies operating in the single cell multiomics market are developing single-cell multiomics tests to enhance the accuracy and resolution of cellular analysis. Single-cell multiomics tests enable researchers to better understand complex biological processes, identify rare cell populations, and tailor precision medicine approaches by integrating comprehensive molecular data from individual cells. For instance, in June 2024, Mission Bio, a US-based biotechnology company, launched Tapestri Single-cell Multiple Myeloma Multiomics Solution, which enables comprehensive profiling of multiple myeloma at single-cell resolution. This solution enables translational researchers and drug developers to fully dissect the molecular and cellular landscape during myeloid progression, understand therapy resistance, and identify drivers of disease evolution from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Which leading companies are dominating the single cell multiomics market landscape?
Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd., 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd., Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS
Which geographic areas are expected to offer the highest growth opportunities in thesingle cell multiomics market?
North America was the largest region in the single cell multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Single Cell Multiomics Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20630
Need Customized Data On Single Cell Multiomics Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
